Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-05 Sale | 2024-02-05 6:11 pm | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 36,248 | $2.2209 | $80,503 | 2,731,624 (Direct) | View |
| 2023-11-20 Purchase | 2023-11-22 5:09 pm | Verona Pharma plc | VRNA | Edwards Martin Director | 33,736 | $1.837 | $61,973 | 144,800 (Direct) | View |
| 2023-11-06 Purchase | 2023-11-08 4:15 pm | Verona Pharma plc | VRNA | EBSWORTH DAVID R Director | 160,000 | $1.9755 | $316,080 | 844,643 (Direct) | View |
| 2023-11-03 Sale | 2023-11-03 8:11 pm | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 58,752 | $1.92 | $112,804 | 2,840,640 (Direct) | View |
| 2023-08-03 Sale | 2023-08-07 9:19 pm | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 80,144 | $2.5276 | $202,576 | 2,872,528 (Direct) | View |
| 2023-08-03 Sale | 2023-08-07 9:17 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 275,888 | $2.5151 | $693,897 | 16,431,800 (Direct) | View |
| 2023-08-03 Sale | 2023-08-07 9:17 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 275,888 | $2.5151 | $693,897 | 15,521,248 (Direct) | View |
| 2023-08-03 Sale | 2023-08-07 9:15 pm | Verona Pharma plc | VRNA | Poll Claire General Counsel | 48,472 | $2.5151 | $121,914 | 2,681,623 (Indirect Direct) | View |
| 2023-08-01 Sale | 2023-08-03 8:31 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 179,648 | $2.6437 | $474,938 | 15,797,136 (Direct) | View |
| 2023-08-01 Sale | 2023-08-03 8:30 pm | Verona Pharma plc | VRNA | Poll Claire General Counsel | 31,552 | $2.6437 | $83,415 | 2,730,095 (Indirect Direct) | View |
| 2023-08-01 Sale | 2023-08-03 8:29 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 179,648 | $2.6437 | $474,938 | 16,707,688 (Direct) | View |
| 2023-08-01 Sale | 2023-08-03 8:27 pm | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 33,464 | $2.6437 | $88,469 | 2,952,672 (Direct) | View |
| 2023-05-11 Sale | 2023-05-15 6:07 pm | Verona Pharma plc | VRNA | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director | 482,913 | $20.58 | $9,938,132 | 3,777,778 (Indirect) | View |
| 2023-05-11 Sale | 2023-05-15 6:06 pm | Verona Pharma plc | VRNA | Gupta Rishi Director | 482,913 | $20.58 | $9,938,132 | 3,777,778 (Indirect) | View |
| 2023-05-01 Sale | 2023-05-03 7:49 pm | Verona Pharma plc | VRNA | Poll Claire General Counsel | 80,376 | $2.5759 | $207,041 | 2,753,319 (Indirect Direct) | View |
| 2023-05-01 Sale | 2023-05-03 7:49 pm | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 106,176 | $2.5964 | $275,678 | 2,971,136 (Direct) | View |
| 2023-05-01 Sale | 2023-05-03 7:48 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 455,528 | $2.5759 | $1,173,395 | 15,976,784 (Direct) | View |
| 2023-05-01 Sale | 2023-05-03 7:46 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 455,536 | $2.5759 | $1,173,415 | 16,887,336 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-01 Option Award | 2024-04-02 4:15 pm | N/A 2034-03-31 | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 2,400,000 | $0 | 2,400,000 (Direct) | View |
| 2024-02-01 Tax Withholding | 2024-02-05 6:11 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 480,200 | $2.2938 | 15,942,592 (Direct) | View |
| 2024-02-01 Tax Withholding | 2024-02-05 6:11 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 72,768 | $2.2938 | 2,731,624 (Direct) | View |
| 2024-02-01 Tax Withholding | 2024-02-05 6:10 pm | N/A N/A | Verona Pharma plc | VRNA | Poll Claire General Counsel | 103,408 | $2.2938 | 2,800,407 (Direct) | View |
| 2024-02-01 Gift | 2024-02-05 6:10 pm | N/A N/A | Verona Pharma plc | VRNA | Poll Claire General Counsel | 116,592 | $0 | 2,800,407 (Direct) | View |
| 2024-02-01 Tax Withholding | 2024-02-05 6:09 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 480,664 | $2.2938 | 15,031,576 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-02 06:07 am | N/A 2034-01-31 | Verona Pharma plc | VRNA | Austwick Michael Director | 144,000 | $0 | 144,000 (Direct) | View |
| 2023-11-01 Tax Withholding | 2023-11-03 8:11 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 173,136 | $1.7438 | 2,840,640 (Direct) | View |
| 2023-11-01 Gift | 2023-11-03 8:09 pm | N/A N/A | Verona Pharma plc | VRNA | Poll Claire General Counsel | 196,096 | $0 | 2,707,719 (Direct) | View |
| 2023-11-01 Tax Withholding | 2023-11-03 8:09 pm | N/A N/A | Verona Pharma plc | VRNA | Poll Claire General Counsel | 173,904 | $1.7438 | 2,707,719 (Direct) | View |
| 2023-11-01 Tax Withholding | 2023-11-03 8:09 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 809,008 | $1.7438 | 16,422,792 (Direct) | View |
| 2023-11-01 Tax Withholding | 2023-11-03 8:08 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 809,008 | $1.7438 | 15,512,240 (Direct) | View |
| 2023-10-20 Option Award | 2023-10-24 4:06 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 800,000 | $0 | 17,231,800 (Direct) | View |
| 2023-10-20 Option Award | 2023-10-24 4:06 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 200,000 | $0 | 3,072,528 (Direct) | View |
| 2023-10-20 Option Award | 2023-10-24 4:06 pm | N/A N/A | Verona Pharma plc | VRNA | Poll Claire General Counsel | 200,000 | $0 | 2,881,623 (Direct) | View |
| 2023-10-20 Option Award | 2023-10-24 4:05 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 800,000 | $0 | 16,321,248 (Direct) | View |
| 2023-09-01 Option Award | 2023-09-05 4:05 pm | N/A 2033-08-31 | Verona Pharma plc | VRNA | ACKERMANN CHRISTINA Director | 144,000 | $0 | 144,000 (Direct) | View |
| 2023-08-07 Gift | 2023-08-07 9:15 pm | N/A N/A | Verona Pharma plc | VRNA | Poll Claire General Counsel | 89,976 | $0 | 2,681,623 (Direct) | View |
| 2023-05-01 Exercise(A) | 2023-05-11 4:16 pm | N/A 2029-03-29 | Verona Pharma plc | VRNA | Poll Claire General Counsel | 8,328 | $0 | 1,987,391 (Direct) | View |
| 2023-05-01 Exercise(A) | 2023-05-11 4:15 pm | N/A 2029-03-29 | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 15,000 | $0 | 2,986,136 (Direct) | View |
| 2023-04-28 Option Award | 2023-04-28 4:24 pm | N/A 2033-04-27 | Verona Pharma plc | VRNA | Deschamps Lisa Director | 96,000 | $0 | 96,000 (Direct) | View |
| 2023-04-28 Option Award | 2023-04-28 4:23 pm | N/A 2033-04-27 | Verona Pharma plc | VRNA | Ullman Anders Director | 96,000 | $0 | 96,000 (Direct) | View |
| 2023-04-28 Option Award | 2023-04-28 4:23 pm | N/A 2033-04-27 | Verona Pharma plc | VRNA | SHAH MAHENDRA Director | 96,000 | $0 | 96,000 (Direct) | View |
| 2023-04-28 Option Award | 2023-04-28 4:23 pm | N/A 2033-04-27 | Verona Pharma plc | VRNA | EBSWORTH DAVID R Director | 96,000 | $0 | 96,000 (Direct) | View |